Literature DB >> 14178016

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

R L NIENHUIS, E MANDEMA.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FLUORESCENT ANTIBODY TECHNIC; GERIATRICS; LUPUS ERYTHEMATOSUS, SYSTEMIC

Mesh：

Substances：

Year:  1964        PMID： 14178016      PMCID： PMC1030930          DOI： 10.1136/ard.23.4.302

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Variations in the morphological patterns of "autoimmune" nuclear fluorescence.

Authors:  J S BECK
Journal:  Lancet       Date:  1961-06-03       Impact factor: 79.321

2.  POPULATION STUDIES OF RHEUMATIC DISEASES ON A COSTAL ISLAND. I. CLINICAL AND SEROLOGICAL STUDY.

Authors:  J J DE BLECOURT; F WESTENDORPBOERMA
Journal:  Ann Rheum Dis       Date:  1963-11       Impact factor: 19.103

3.  Quantitative observations on antinuclear factors in systemic lupus erythematosus.

Authors:  E MANDEMA; V E POLLAK; R M KARK; J REZAIAN
Journal:  J Lab Clin Med       Date:  1961-09

4.  Anti-cytoplasmic factors in the sera of patients with systemic lupus erythematosus and certain other diseases.

Authors:  H R DEICHER; H R HOLMAN; H G KUNKEL
Journal:  Arthritis Rheum       Date:  1960-02

5.  Electron microscope studies of keratinization as observed in gingiva and cheek mucosa.

Authors:  J T ALBRIGHT
Journal:  Ann N Y Acad Sci       Date:  1960-03-29       Impact factor: 5.691
  5 in total
  114 in total

1.  Unlocking the "PAD" lock on rheumatoid arthritis.

Authors:  P J Utz; M C Genovese; W H Robinson
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

Review 2.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

3.  Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.

Authors:  Altan Ercan; Jing Cui; Dereck E W Chatterton; Kevin D Deane; Melissa M Hazen; William Brintnell; Colin I O'Donnell; Lezlie A Derber; Michael E Weinblatt; Nancy A Shadick; David A Bell; Ewa Cairns; Daniel H Solomon; V Michael Holers; Pauline M Rudd; David M Lee
Journal:  Arthritis Rheum       Date:  2010-08

4.  Pathomechanisms in rheumatoid arthritis--time for a string theory?

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

5.  Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF.

Authors:  I G Silveira; R W Burlingame; C A von Mühlen; A L Bender; H L Staub
Journal:  Clin Rheumatol       Date:  2007-04-05       Impact factor: 2.980

6.  Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response?

Authors:  P E Spronk; E J ter Borg; C G Kallenberg
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

7.  Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis.

Authors:  Kristine A Kuhn; Liudmila Kulik; Beren Tomooka; Kristin J Braschler; William P Arend; William H Robinson; V Michael Holers
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

8.  The perinuclear factor, a rheumatoid arthritis-specific autoantigen, is not present in keratohyalin granules of cultured buccal mucosa cells.

Authors:  R M Hoet; R A Voorsmit; W J Van Venrooij
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

9.  Association of anti-CCP positivity with serum ferritin and DAS-28.

Authors:  Burcu Önder; Aydan Kurtaran; Songül Kimyon; Barin Selçuk; Müfit Akyüz
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

10.  Significance of anti-CCP antibodies in modification of 1987 ACR classification criteria in diagnosis of rheumatoid arthritis.

Authors:  Jinxia Zhao; Xiangyuan Liu; Zhimin Wang; Zhanguo Li
Journal:  Clin Rheumatol       Date:  2009-10-15       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.